Alexander Maximilian Aldejohann (Alexander Aldejohann)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Extracorporeal Membrane Oxygenation

Intensive Care Unit

Candida Albicans

Top Venues

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander Maximilian Aldejohann, Carolina Menner, Nadja Thielemann, Ronny Martin, Grit Walther, Oliver Kurzai
In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains. Antimicrobial agents and chemotherapy 68 (2) (2024)
Alexander Maximilian Aldejohann, Carolina Menner, Nadja Thielemann, Ronny Martin, Grit Walther, Oliver Kurzai
In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains. Antimicrobial agents and chemotherapy 68 (2) (2024)
Alexander Maximilian Aldejohann, Carolina Menner, Nadja Thielemann, Ronny Martin, Grit Walther, Oliver Kurzai
In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains. Antimicrobial agents and chemotherapy 68 (2) (2024)
Alexander Maximilian Aldejohann, Carolina Menner, Nadja Thielemann, Ronny Martin, Grit Walther, Oliver Kurzai
In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains. Antimicrobial agents and chemotherapy 68 (2) (2024)
Alexander Maximilian Aldejohann, Carolina Menner, Nadja Thielemann, Ronny Martin, Grit Walther, Oliver Kurzai
In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains. Antimicrobial agents and chemotherapy 68 (2) (2024)
Alexander Maximilian Aldejohann, Carolina Menner, Nadja Thielemann, Ronny Martin, Grit Walther, Oliver Kurzai
In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains. Antimicrobial agents and chemotherapy 68 (2) (2024)
Alexander Maximilian Aldejohann, Carolina Menner, Nadja Thielemann, Ronny Martin, Grit Walther, Oliver Kurzai
In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains. Antimicrobial agents and chemotherapy (2024)
Carl Hinrichs, Miriam Wiese-Posselt, Barbara Graf, Christine Geffers, Beate Weikert, Philipp Enghard, Alexander Maximilian Aldejohann, Annette Schrauder, Andreas Knaust, Kai Uwe Eckardt, Petra Gastmeier, Oliver Kurzai
Successful control of Candida auris transmission in a German COVID-19 intensive care unit. Mycoses 65 (6) (2022)